NPY and Alzheimer disease: Salomon and Baran’s observation that NPY is significantly elevated in the plasma of AD patients was further supported by Hodeib and colleagues, who found that plasma NPY is significantly elevated in AD patients with moderate and severe disease compared to patients with mild AD and healthy volunteers (Table 1) (64).